These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 482818)

  • 1. [Indications, dosage and combinations of the major antitubercular drugs].
    Lebeau B; Rochemaure J
    Rev Prat; 1979 Jun; 29(33):2653-65. PubMed ID: 482818
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG; Lötter AP
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of isoniazid and rifampicin regimens on the liver of tuberculosis patients].
    Pilheu JA; De Salvo MC; Barcat JA
    Medicina (B Aires); 1979; 39(3):298-304. PubMed ID: 514051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isoprodian in combination with ethambutol and rifampicin in the treatment of tuberculosis (author's transl)].
    Hoose C
    Prax Pneumol; 1975 Sep; 29(9):517-9. PubMed ID: 1208336
    [No Abstract]   [Full Text] [Related]  

  • 5. The suitability of new drugs for intermittent chemotherapy of tuberculosis. An experimental study.
    Dickinson JM
    Scand J Respir Dis Suppl; 1969; 69():91-8. PubMed ID: 4190279
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recommendations for the therapy of tuberculosis. (Position: December, 1988)].
    Merkel S; Fischer P; Weinecke W
    Z Erkr Atmungsorgane; 1989; 173(1):87-96. PubMed ID: 2800620
    [No Abstract]   [Full Text] [Related]  

  • 7. An experimental attempt of intensified chemotherapy with rifampicin combined with other drugs.
    Hokama S
    Jpn J Tuberc Chest Dis; 1971 Jul; 17(1):57-61. PubMed ID: 5317096
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
    Danckwerts MP; Ebrahim S; Pillay V
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of experimental tuberculosis in guinea pigs by continuous and intermittent regimen with special reference to ethambutol and rifampicin].
    Westfal I; Wiza J; Rudnicka M; Szymaczek-Meyer L
    Gruzlica; 1973 Jan; 41(1):1-8. PubMed ID: 4686876
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 11. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S; Sasaki M; Kobayashi T; Matsuda T
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug; 37(954):67-70. PubMed ID: 7616907
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Rifampin in the treatment of tuberculosis.
    Grzybowshi S
    Can Med Assoc J; 1974 May; 110(9):1002 passim. PubMed ID: 4823101
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of tuberculosis in Haiti.
    Long R; Scalcini M; Ollé-Goig J
    Am J Public Health; 2001 Oct; 91(10):1546-7. PubMed ID: 11574298
    [No Abstract]   [Full Text] [Related]  

  • 17. [Question of bactericidal effect of a combination of maximally tolerable doses of INH, Myambutol and Rifadin on experimental tuberculosis].
    Djurisić M; Davidović C; Leposavić M; Jovancvić M; Marković L; Popović S
    Plucne Bolesti Tuberk; 1973; 25(3):251-6. PubMed ID: 4210992
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
    Nitti V
    Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
    [No Abstract]   [Full Text] [Related]  

  • 19. Intermittent chemotherapy for adults with tuberculosis.
    Am Rev Respir Dis; 1974 Sep; 110(3):374-6. PubMed ID: 4413938
    [No Abstract]   [Full Text] [Related]  

  • 20. Three-in-one TB drug approved.
    Posit Aware; 1995; ():5. PubMed ID: 11362378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.